These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17768676)

  • 1. Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity.
    Dhanasekaran M; Albano CB; Pellet L; Karuppagounder SS; Uthayathas S; Suppiramaniam V; Brown-Borg H; Ebadi M
    Neurochem Res; 2008 Jun; 33(6):980-4. PubMed ID: 17768676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
    Johannessen JN
    Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
    Di Monte DA; Royland JE; Anderson A; Castagnoli K; Castagnoli N; Langston JW
    J Neurochem; 1997 Oct; 69(4):1771-3. PubMed ID: 9326308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein-I and -II knock-out mice are not more sensitive than control mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
    Rojas P; Klaassen CD
    Neurosci Lett; 1999 Oct; 273(2):113-6. PubMed ID: 10505629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K; Palmer S; Castagnoli N
    Neurobiology (Bp); 1999; 7(2):135-49. PubMed ID: 10591048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
    Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
    Heikkila RE; Hwang J; Ofori S; Geller HM; Nicklas WJ
    J Neurochem; 1990 Mar; 54(3):743-50. PubMed ID: 2303810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum.
    Thomas B; Mohanakumar KP
    J Pineal Res; 2004 Jan; 36(1):25-32. PubMed ID: 14675127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
    Chan P; Langston JW; Di Monte DA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection.
    Singh S; Singh K; Patel DK; Singh C; Nath C; Singh VK; Singh RK; Singh MP
    Rejuvenation Res; 2009 Jun; 12(3):185-97. PubMed ID: 19594327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
    Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
    Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-methyl-4-phenylpyridinium (MPP+) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake.
    Johnson EA; Wu EY; Rollema H; Booth RG; Trevor AJ; Castagnoli N
    Eur J Pharmacol; 1989 Jul; 166(1):65-74. PubMed ID: 2806366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
    Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
    Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
    Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
    Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.